Jecure Therapeutics Inc.
4757 Nexus Center Drive
About Jecure Therapeutics Inc.
Jecure Therapeutics is focused on the discovery of novel therapeutics for the treatment of fatty liver disease, NASH, and fibrosis. Our scientific founder is Dr. Ariel Feldstein, Division Chief of Gastroenterology at UCSD School of Medicine and a leading physician scientist in hepatology. Jecure Therapeutics combines cutting-edge academic biology with deeply experienced pharma/biotech scientists who are dedicated to discovering novel and impactful therapeutics for the treatment of liver disease.
Founder: Ariel Feldstein
President and CEO: Jeffrey A. Stafford, PhD
CSO: James M. Veal, PhD
Currently, there are no jobs for this employer on BioSpace.
Browse jobs with BioSpace Featured Employers here.